These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 3193012)
1. [Immunomodulating capacity of monocyte-macrophage system in cancer patients]. Umesaki N; Ohshika Y; Sugawa T Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1638-44. PubMed ID: 3193012 [No Abstract] [Full Text] [Related]
2. Testing the monocyte-macrophage system in human cancer. Samak R; Edelstein R; Bogucki D; Samak M; Israƫl L Biomedicine; 1980 Dec; 32(4):165-9. PubMed ID: 7008857 [TBL] [Abstract][Full Text] [Related]
3. Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis. Bernhard MI; Pace RC; Unger SW; Wanebo HJ Cancer Res; 1983 Sep; 43(9):4504-10. PubMed ID: 6871879 [TBL] [Abstract][Full Text] [Related]
4. A comparison of antibody dependent cellular cytotoxic potential in macrophages obtained from normal donors and cancer patients. Cameron DJ Jpn J Exp Med; 1985 Jun; 55(3):81-7. PubMed ID: 3910883 [TBL] [Abstract][Full Text] [Related]
5. [The monocyte-macrophage system in the human]. Speer CP; Gahr M Monatsschr Kinderheilkd; 1989 Jul; 137(7):390-5. PubMed ID: 2677685 [TBL] [Abstract][Full Text] [Related]
6. Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1, and migration in HT-29 colon cancer cells. Li YY; Chang JW; Hsieh LL; Yeh KY Cell Immunol; 2010; 265(2):164-71. PubMed ID: 20851386 [TBL] [Abstract][Full Text] [Related]
8. Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance. Snyderman R; Pike MC Am J Pathol; 1977 Sep; 88(3):727-39. PubMed ID: 196506 [TBL] [Abstract][Full Text] [Related]
9. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid. Baughman RP; Mangels DJ; Strohofer S; Corser BC J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142 [TBL] [Abstract][Full Text] [Related]
11. [Role of monocytes and macrophages in the defense against malignant tumors]. Schuurman B; Meyer S; Beelen RH Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1978-81. PubMed ID: 8965926 [No Abstract] [Full Text] [Related]
12. Monocyte and macrophage heterogeneity and Toll-like receptors in the lung. Schneberger D; Aharonson-Raz K; Singh B Cell Tissue Res; 2011 Jan; 343(1):97-106. PubMed ID: 20824285 [TBL] [Abstract][Full Text] [Related]
13. Monocyte and macrophage killing of helicobacter pylori: relationship to bacterial virulence factors. Borlace GN; Butler RN; Brooks DA Helicobacter; 2008 Oct; 13(5):380-7. PubMed ID: 19250513 [TBL] [Abstract][Full Text] [Related]
14. [Immunologic studies on the patients with gastrointestinal cancer--with particular reference to correlation between T lymphocyte and macrophage]. Fujimoto S; Ishigami H; Kitsukawa Y; Amemiya K; Ohyama Y; Kure M; Endoh F; Okui K Gan To Kagaku Ryoho; 1982 Mar; 9(3):534-9. PubMed ID: 6985192 [TBL] [Abstract][Full Text] [Related]
15. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species. Weinberg JB; Haney AF J Natl Cancer Inst; 1983 Jun; 70(6):1005-10. PubMed ID: 6574267 [TBL] [Abstract][Full Text] [Related]